Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra
AssigneeUniversity of Connecticut
InventorsLeo Lefrancois, Thomas A. Stoklasek
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Connecticut
InventorsLeo Lefrancois, Thomas A. Stoklasek
Estimating the term…
The present invention relates to a therapeutic polypeptide and methods for its creation and use for modulating an immune response in a host organism in need thereof. In particular, the invention relates to the administration to an organism in need thereof, of an effective amount of a pre-coupled polypeptide complex comprising a lymphokine polypeptide portion, for example IL-15 (SEQ ID NO: 5, 6), IL-2 (SEQ ID NO: 10, 12) or combinations of both, and an interleukin receptor polypeptide portion, for example IL-15Ra (SEQ ID NO: 7, 8), IL-2Ra (SEQ ID NO: 9, 11) or combinations of both, for augmenting the immune system in, for example, cancer, SCID, AIDS, or vaccination; or inhibiting the immune system in, for example, rheumatoid arthritis, or Lupus. The therapeutic complex of the invention surprisingly demonstrates increased half-life, and efficacy in vivo.
A method for increasing proliferation of immune cells, comprising administering to a human an effective amount of a composition, wherein the composition comprises:
A method for driving homeostatic proliferation of lymphokine responsive immune cells, comprising administering to a human an effective amount of a composition, wherein the composition comprises:
Dependencies are inferred from the claim text.